Hikma Pharmaceuticals PLC (LON:HIK) Given Consensus Recommendation of Moderate Buy by Brokerages

Hikma Pharmaceuticals PLC (LON:HIK – Get Rating) has been assigned an average recommendation of “Moderate Buy” from the six ratings firms that are presently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month target […]

Related Keywords

Canada , ,Hikma Pharmaceuticals Price Performance ,Analyst Recommendations For Hikma Pharmaceuticals ,Royal Bank ,Barclays ,Jpmorgan Chase Co ,Hikma Pharmaceuticals ,Jefferies Financial Group ,Berenberg Bank ,Hikma Pharmaceuticals Increases Dividend ,News Ratings For Hikma Pharmaceuticals Daily ,Get Rating ,Hikma Pharmaceuticals Daily ,Lon Hik ,Zhik ,Medical ,Ratings ,Consensus ,